Dr. Mimi Hu is an oncologic endocrinologist, Professor and Deputy Chair of Clinical Affairs in the Department of Endocrinology and Hormonal Disorders at the University of Texas MD Anderson Cancer Center in Houston, Texas USA. She is the program director of the Oncologic Endocrine Fellowship program. Dr. Hu's clinical expertise is in the evaluation and treatment of patients with thyroid carcinoma with a special focus on medullary thyroid cancer and hereditary endocrine neoplasia disorders. She is the co-chair of the ATA's Guidelines Committee for the "Update on Systemic Therapies for Medullary Thyroid Carcinoma" and the primary investigator and collaborator on multiple clinical trials evaluating various targeted therapies for advanced thyroid carcinoma. She has published articles and book chapters evaluating the management of medullary thyroid carcinoma, multiple endocrine neoplasia, bone health in cancer patients, endocrine complications of head and neck surgery, and paraneoplastic endocrine disorders.